There are 717 resources available
381MO - Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib)
Presenter: Keunchil Park
Session: Mini oral session on Thoracic cancers
Resources:
Abstract
Slides
Webcast
299MO - Efficacy and safety of entrectinib in an Asian population with <italic>NTRK</italic> fusion-positive (fp) solid tumours or <italic>ROS1</italic>-fp NSCLC
Presenter: Daniel Shao Weng Tan
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
300MO - Impact of dihydropyrimidine dehydrogenase (DPD) genotype on fluoropyrimidine-related toxicity in Asian population
Presenter: Masashi Kanai
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
301MO - Genomic HLA as a predictive biomarker for survival among non-small cell lung cancer patient treated with single agent immunotherapy
Presenter: Afaf Abed
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
302MO - Development of a flow cytometry-based whole-blood prognostic immune signature in metastatic cancer patients treated with immune checkpoint inhibitors
Presenter: Jian-Guo Zhou
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
303MO - Single-cell analysis reveals the interaction between M2 macrophages and NK cells underlying immune types associated with cancer immunotherapy response
Presenter: Anlin Li
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
70MO - Efficacy and safety of envafolimab (KN035) in advanced tumours with mismatch-repair deficiency
Presenter: Jian Li
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Webcast
71MO - OBI-833 was safe and immunogenic, without treatment-related SAEs, in a phase I dose-escalation trial
Presenter: Her-shyong Shiah
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
72MO - Selinexor in combination with standard chemotherapy in patients with advanced solid tumours: Results of an open label, single-center, multi-arm phase Ib study
Presenter: Kyaw Thein
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
115MO - Long-term efficacy, tolerability and overall survival in patients (pts) with unresectable or metastatic (U/M) PDGFRA D842V-mutant gastrointestinal stromal tumour (GIST) treated with avapritinib: NAVIGATOR phase I trial update
Presenter: Yoon-Koo Kang
Session: Mini oral session on Gastrointestinal tumours 1
Resources:
Abstract
Slides
Webcast